7.05
Mimedx Group Inc stock is traded at $7.05, with a volume of 1.11M.
It is down -4.99% in the last 24 hours and down -1.54% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$7.42
Open:
$7.48
24h Volume:
1.11M
Relative Volume:
1.76
Market Cap:
$933.48M
Revenue:
$342.81M
Net Income/Loss:
$97.67M
P/E Ratio:
11.47
EPS:
0.6145
Net Cash Flow:
$50.46M
1W Performance:
+11.55%
1M Performance:
-1.54%
6M Performance:
-6.37%
1Y Performance:
-2.62%
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
6.49 | 0 | 0 | 0 | 0 | 0.00 | |
![]()
GOODO
Gladstone Commercial Corporation
|
20.37 | 372.90M | 0 | 0 | 0 | 0.00 |
![]()
PSNYW
Polestar Automotive Holding Uk
|
0.1612 | 337.87M | 2.07B | -1.42B | -1.37B | -0.6765 |
![]()
MOBBW
Mobilicom Limited Warrants
|
0.28 | 291.74M | 0 | 0 | 0 | 0.00 |
![]()
JUNE
Dhandho Junoon Etf
|
10.95 | 226.20M | 0 | 0 | 0 | 0.00 |
![]()
SHMD
Schmid Group N V
|
3.46 | 172.25M | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
Mar-07-24 | Initiated | Lake Street | Buy |
Oct-27-23 | Initiated | Craig Hallum | Buy |
Oct-13-22 | Initiated | Mizuho | Buy |
Jul-26-21 | Initiated | Northland Capital | Outperform |
Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
MiMedx Group CEO & Director Acquires 61% More Stock - simplywall.st
MiMedx Group's (NASDAQ:MDXG) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
MIMEDX to Present at the BofA Securities 2025 Healthcare Conference - GlobeNewswire
MIMEDX Leadership Takes Stage at BofA Healthcare Conference: Key Updates Expected - Stock Titan
Hedge Fund and Insider Trading News: Bill Ackman, Ken Griffin, Warren Buffett, Phill Gross, Armistice Capital, NVIDIA Corporation (NVDA), MiMedx Group Inc (MDXG), and More - Insider Monkey
MiMedx Group Insider Bought Shares Worth $1,268,000, According to a Recent SEC Filing - marketscreener.com
MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS) - GlobeNewswire
Reviewing MiMedx Group (NASDAQ:MDXG) and Alphatec (NASDAQ:ATEC) - Defense World
Northland Capmk Predicts Weaker Earnings for MiMedx Group - Defense World
US$12.20: That's What Analysts Think MiMedx Group, Inc. (NASDAQ:MDXG) Is Worth After Its Latest Results - Yahoo Finance
MiMedx Group (NASDAQ:MDXG) Stock Rating Upgraded by StockNews.com - Defense World
Market Momentum: Mimedx Group Inc (MDXG) Registers a -8.14 Decrease, Closing at 6.32 - DWinneX
MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2025 Earnings Call Transcript - Insider Monkey
Wells Fargo & Company MN Has $674,000 Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
MIMEDX Earnings Call: Growth Amid Challenges - TipRanks
MiMedx (MDXG) Faces Price Target Cut Amid Medicare Coverage Dela - GuruFocus
MiMedx (MDXG) Sees Price Target Cut by Mizuho After Earnings Rel - GuruFocus
MiMedx (MDXG) Faces Price Target Cut Amid Medicare Coverage Delays | MDXG Stock News - GuruFocus
MiMedx (MDXG) Sees Price Target Cut by Mizuho After Earnings Release | MDXG Stock News - GuruFocus
Decoding MiMedx Group Inc (MDXG): A Strategic SWOT Insight - GuruFocus
MiMedx Group Inc (MDXG) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges - Yahoo Finance
MiMedx: Q1 Earnings Snapshot - CT Insider
MiMedx (MDXG) Reports Q1 Revenue Surpassing Expectations | MDXG Stock News - GuruFocus
MiMedx Reports Q1 2025 Financial Results - TipRanks
MiMedx (MDXG) Reports Modest Q1 Growth and Strong Margin Performance - GuruFocus
MiMedx Group Inc Reports Q1 2025 Earnings: Revenue at $88M Beats Estimates, EPS of $0.05 Misses Expectations - GuruFocus
Earnings Flash (MDXG) Mimedx Group Posts Q1 Adjusted EPS $0.05, vs. FactSet Est of $0.05 - marketscreener.com
MiMedx Group Reports Q1 2025 Financial Results - TipRanks
MIMEDX Announces First Quarter 2025 Operating and Financial Results - The Manila Times
Recent Insider Activity Suggests Potential Gains for Mimedx Group Inc (MDXG) - knoxdaily.com
Head-To-Head Review: Calmare Therapeutics (OTCMKTS:CTTC) vs. MiMedx Group (NASDAQ:MDXG) - Defense World
A Peek at MiMedx Group's Future Earnings - Nasdaq
MiMedx Group (MDXG) Projected to Post Quarterly Earnings on Wednesday - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Geode Capital Management LLC Decreases Stock Position in MiMedx Group, Inc. (NASDAQ:MDXG) - The AM Reporter
JPMorgan Chase & Co. Acquires 395,739 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
LPL Financial LLC Purchases 98,004 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
Cantor Fitzgerald Comments on MiMedx Group FY2025 Earnings - Defense World
StockNews.com Downgrades MiMedx Group (NASDAQ:MDXG) to Buy - Defense World
Some Shareholders Feeling Restless Over MiMedx Group, Inc.'s (NASDAQ:MDXG) P/E Ratio - simplywall.st
MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30 - GlobeNewswire
MIMEDX Sets Date for Q1 2025 Financial Results: Key Details for Investors - Stock Titan
MiMedx (MDXG) Considered an Attractive Investment Opportunity | - GuruFocus
Vanguard Group Inc. Sells 262,667 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
MiMedx (MDXG) Considered an Attractive Investment Opportunity | MDXG Stock News - GuruFocus
MIMEDX to Feature Growing Body of Clinical and Scientific - GlobeNewswire
MIMEDX Breakthrough: New Clinical Data Reveals Expanded Surgical Applications - Stock Titan
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mimedx Group Inc Stock (MDXG) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Maersk-Moller Kimberly | Chief Commercial Officer |
Mar 17 '25 |
Sale |
8.04 |
1,759 |
14,142 |
309,077 |
Hulse William Frank IV | General Counsel and CAO |
Mar 13 '25 |
Sale |
7.89 |
54,596 |
430,762 |
440,178 |
Maersk-Moller Kimberly | Chief Commercial Officer |
Mar 13 '25 |
Sale |
7.89 |
4,106 |
32,396 |
310,836 |
Hulse William Frank IV | General Counsel and CAO |
Mar 10 '25 |
Sale |
7.80 |
81,446 |
635,279 |
494,774 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):